[Business Wire] - ARIAD Pharmaceuticals, Inc. today announced that it will hold a conference call for the investment community tomorrow, April 4, 2013 to provide an update on its progress over the past several weeks with both its commercial launch of Iclusig™ in the United States and its clinical development programs for Iclusig and AP26113.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment